<DOC>
	<DOC>NCT00263354</DOC>
	<brief_summary>To determine the objective response to oxaliplatin/5FU/leucovorin combination chemotherapy in patients with advanced unresectable or metastatic gastric cancer.</brief_summary>
	<brief_title>Oxaliplatin in Gastric Cancer</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>ECOG performance status of 02. Histologically proven gastric or gastroesophageal junction adenocarcinoma. At least unidimensional measurable disease. If a unique metastasis constitutes the only disease sign, it requires histological confirmation. First line locally unresectable or metastatic gastric cancer. Relapsing gastric cancer after local and/or systemic treatment with a postsurgical period of at least 4 weeks, a postadjuvant or neoadjuvant chemoradiotherapy period of at least 6 months. Serum bilirubin &lt; 2 mg/dl Serum creatinine &lt; or = 2 mg/dl Hemoglobin &gt; or = 10 g/dl Absolute neutrophil count &gt; or = 2000/dl Platelet count &gt;or = 100, 000/dl AST/ALT &lt; or = 2.5 timefold the institutional normal upper limit Alkaline phosphatase &lt; or = 5 timefold the institutional normal upper limit Imagenological evaluation of the patient at least 2 weeks prior to the drug infusion Laboratory tests at least 1 week prior to the first infusion Patient available for follow up and able to answer to the quality of life questionnaire Symptomatic sensorial peripheral neuropathy Uncontrolled concomitant disease Another malignant neoplastic disease diagnosed within the previous 5 years to the diagnosis of advanced or metastatic gastric cancer, with the exception of 'in situ' cervix carcinoma or nonmelanoma skin cancer Concomitant antitumoral treatment Cerebral metastases Unstable heart disease, even though in treatment Myocardial infarction within the last 6 months Radiotherapy within the last 6 weeks, surgery within the last 4 weeks, or chemotherapy within the last 6 months. Pregnancy or nursing ( or women in reproductive life without adequate contraception) Significant neurological or psychiatric disorders.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>